Luxembourg, 23 October 2018 - Members of EBAN, the European Business Angel Network, voted Sensius to be the winner of the 2018 Pitching…
The most recent questionnaire for sarcoma centers as published by the DKG, the German Cancer Society, now includes the requirement to…
The Technical University Eindhoven has appointed Maarten Paulides, co-founder of Sensius, to be the new scientific director of the Center…
On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and Medium sized Enterprises (EASME…
Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May 2018 in Berlin, hosted…
In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on financing of startups…
Sensius won the Venture Cup Award of Startup Olé SalamancaCompanies with the European Seal of Excellence from the European Agence for Small…
In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 magazine about thermotherapy and the very…
In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation for Health, the…
MedValue: "High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer". The prognosis of…
Gerard van Rhoon was honored by receiving the 28th J. Eugene Robinson1 award, which is the most prestigious price of the Annual Congress of…
Sensius, an Erasmus MC Spinoff company developing novel cancer treatment using hyperthermia, is receiving €300,000 from the UNIIQ…
